{
    "clinical_study": {
        "@rank": "33679", 
        "brief_summary": {
            "textblock": "RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells and may be an\n      effective treatment for patients with anaplastic astrocytomas.\n\n      PURPOSE: Randomized phase III trial to study the effectiveness of radiation therapy in\n      treating patients with anaplastic astrocytomas."
        }, 
        "brief_title": "Radiation Therapy in Treating Patients With Brain Cancer", 
        "condition": "Brain and Central Nervous System Tumors", 
        "condition_browse": {
            "mesh_term": [
                "Nervous System Neoplasms", 
                "Central Nervous System Neoplasms"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES: I. Compare the disease-free interval and survival in patients with\n      supratentorial malignant brain gliomas randomized to radiotherapy alone vs. radiotherapy\n      plus radiosensitization with mitolactol (DBD) followed by DBD and carmustine.\n\n      OUTLINE: Randomized study. Group I: Radiotherapy. External-beam cranial irradiation with\n      megavoltage equipment. Group II: Radiotherapy with Radiosensitization followed by\n      Maintenance Chemotherapy. Radiotherapy as in Group I; with Mitolactol, DBD, NSC-104800;\n      followed by DBD; Carmustine, BCNU, NSC-409962.\n\n      PROJECTED ACCRUAL: A total of 212 patients will be entered over more than 3 years."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS: Histologically confirmed anaplastic astrocytoma Standard maximum\n        resection or stereotactic biopsy required within 4 weeks prior to therapy\n\n        PATIENT CHARACTERISTICS: Age: Over 16 Performance status: ECOG/ZUBROD/WHO 0-2 Life\n        expectancy: At least 8 weeks Hematopoietic: WBC greater than 4,000 Platelets greater than\n        100,000 Hematocrit greater than 30% Hepatic: Bilirubin less than 2 mg/dl Renal: Creatinine\n        less than 1.5 mg/dl Creatinine clearance greater than 70 ml/min BUN less than 40 mg/dl\n        Other: No major medical illness\n\n        PRIOR CONCURRENT THERAPY: No anticancer drugs between surgery and protocol treatment No\n        steroids after 10 days following surgery (may be resumed occasionally during radiotherapy)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "16 Years"
        }, 
        "enrollment": {
            "#text": "212", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 1, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002620", 
            "org_study_id": "EORTC-26882", 
            "secondary_id": "EORTC-26882"
        }, 
        "intervention": [
            {
                "intervention_name": "carmustine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "chemotherapy", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "mitolactol", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "low-LET cobalt-60 gamma ray therapy", 
                "intervention_type": "Radiation"
            }, 
            {
                "intervention_name": "low-LET photon therapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Carmustine", 
                "Mitolactol"
            ]
        }, 
        "keyword": "adult anaplastic astrocytoma", 
        "lastchanged_date": "June 29, 2012", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/EORTC-26882"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Vienna (Wien)", 
                        "country": "Austria", 
                        "zip": "A-1100"
                    }, 
                    "name": "Kaiser Franz Josef Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels", 
                        "country": "Belgium", 
                        "zip": "1070"
                    }, 
                    "name": "Hopital Universitaire Erasme"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Brussels (Bruxelles)", 
                        "country": "Belgium", 
                        "zip": "1090"
                    }, 
                    "name": "Academisch Ziekenhuis der Vrije Universiteit Brussel"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleroi", 
                        "country": "Belgium", 
                        "zip": "6000"
                    }, 
                    "name": "Hopital Civil de Charleroi"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Liege (Luik)", 
                        "country": "Belgium", 
                        "zip": "4000"
                    }, 
                    "name": "Centre Hospitalier Regional de la Citadell"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hannover", 
                        "country": "Germany", 
                        "zip": "D-30559"
                    }, 
                    "name": "Neurologische Klinik der Henriettenstiftung"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Treviso", 
                        "country": "Italy", 
                        "zip": "31100"
                    }, 
                    "name": "Regional Hospital Treviso"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Rotterdam", 
                        "country": "Netherlands", 
                        "zip": "3075 EA"
                    }, 
                    "name": "Rotterdam Cancer Institute"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tilburg", 
                        "country": "Netherlands", 
                        "zip": "5042 SB"
                    }, 
                    "name": "Dr. Bernard Verbeeten Instituut"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands", 
                        "zip": "3508 GA"
                    }, 
                    "name": "Academisch Ziekenhuis Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lisbon", 
                        "country": "Portugal", 
                        "zip": "1093"
                    }, 
                    "name": "Instituto Portugues de Oncologia de Francisco Gentil"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Lausanne", 
                        "country": "Switzerland", 
                        "zip": "CH-1011"
                    }, 
                    "name": "Centre Hospitalier Universitaire Vaudois"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Nottingham", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "NG5 1PB"
                    }, 
                    "name": "Nottingham City Hospital NHS Trust"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Southampton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SO16 6YD"
                    }, 
                    "name": "Southampton General Hospital"
                }
            }
        ], 
        "location_countries": {
            "country": [
                "Austria", 
                "Belgium", 
                "Germany", 
                "Italy", 
                "Netherlands", 
                "Portugal", 
                "Switzerland", 
                "United Kingdom"
            ]
        }, 
        "official_title": "EFFECT OF DIBROMODULCITOL PLUS BCNU ON FREE INTERVAL AND SURVIVAL OF PATIENTS WITH SUPRATENTORIAL MALIGNANT BRAIN GLIOMAS, A PHASE III TYPE STUDY", 
        "overall_official": {
            "affiliation": "Hopital Universitaire Erasme", 
            "last_name": "J. Hildebrand, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "June 2000", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002620"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "results_reference": [
            {
                "PMID": "18248979", 
                "citation": "Hildebrand J, Gorlia T, Kros JM, Afra D, Frenay M, Omuro A, Stupp R, Lacombe D, Allgeier A, van den Bent MJ; on behalf of the EORTC Brain Tumour Group investigators. Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: Results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882). Eur J Cancer. 2008 Jan 11; [Epub ahead of print]"
            }, 
            {
                "PMID": "8058153", 
                "citation": "Hildebrand J, Sahmoud T, Mignolet F, Brucher JM, Afra D. Adjuvant therapy with dibromodulcitol and BCNU increases survival of adults with malignant gliomas. EORTC Brain Tumor Group. Neurology. 1994 Aug;44(8):1479-83."
            }
        ], 
        "source": "European Organisation for Research and Treatment of Cancer - EORTC", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "European Organisation for Research and Treatment of Cancer - EORTC", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 1994", 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2012"
    }, 
    "geocoordinates": {
        "Academisch Ziekenhuis Utrecht": "52.09 5.11", 
        "Academisch Ziekenhuis der Vrije Universiteit Brussel": "50.85 4.352", 
        "Centre Hospitalier Regional de la Citadell": "50.633 5.58", 
        "Centre Hospitalier Universitaire Vaudois": "46.52 6.634", 
        "Dr. Bernard Verbeeten Instituut": "51.586 5.079", 
        "Hopital Civil de Charleroi": "50.411 4.445", 
        "Hopital Universitaire Erasme": "50.85 4.352", 
        "Instituto Portugues de Oncologia de Francisco Gentil": "38.707 -9.136", 
        "Kaiser Franz Josef Hospital": "48.208 16.374", 
        "Neurologische Klinik der Henriettenstiftung": "52.384 9.727", 
        "Nottingham City Hospital NHS Trust": "52.955 -1.158", 
        "Regional Hospital Treviso": "45.666 12.242", 
        "Rotterdam Cancer Institute": "51.924 4.482", 
        "Southampton General Hospital": "50.91 -1.404"
    }
}